受强制性开放获取政策约束的文章 - Suresh Kumar Balasubramanian了解详情
可在其他位置公开访问的文章：15 篇
Liquid biopsy for therapy monitoring in early-stage non-small cell lung cancer
M Nagasaka, MH Uddin, MN Al-Hallak, S Rahman, S Balasubramanian, ...
Molecular Cancer 20, 1-16, 2021
强制性开放获取政策： US National Institutes of Health
Rational management approach to pure red cell aplasia
SK Balasubramanian, M Sadaps, S Thota, M Aly, BP Przychodzen, ...
Haematologica 103 (2), 221, 2018
强制性开放获取政策： US National Institutes of Health
Distinct clinical and biological implications of CUX1 in myeloid neoplasms
M Aly, ZM Ramdzan, Y Nagata, SK Balasubramanian, N Hosono, ...
Blood advances 3 (14), 2164-2178, 2019
强制性开放获取政策： US National Institutes of Health
Real-world outcomes of adult B-cell acute lymphocytic leukemia patients treated with blinatumomab
T Badar, A Szabo, A Advani, M Wadleigh, S Arslan, MA Khan, I Aldoss, ...
Blood Advances 4 (10), 2308-2316, 2020
强制性开放获取政策： US National Institutes of Health
Circular RNAs in acute myeloid leukemia
V Singh, MH Uddin, JA Zonder, AS Azmi, SK Balasubramanian
Molecular cancer 20, 1-10, 2021
强制性开放获取政策： US National Institutes of Health
Fanconi anemia germline variants as susceptibility factors in aplastic anemia, MDS and AML
B Przychodzen, H Makishima, MA Sekeres, SK Balasubramanian, ...
Oncotarget 9 (2), 2050, 2018
强制性开放获取政策： US National Institutes of Health
Sequencing of novel agents in relapsed/refractory B‐cell acute lymphoblastic leukemia: blinatumomab and inotuzumab ozogamicin may have comparable efficacy as first or second …
T Badar, A Szabo, S Dinner, M Liedtke, M Burkart, RM Shallis, ...
Cancer 127 (7), 1039-1048, 2021
强制性开放获取政策： US National Institutes of Health
Molecular patterns identify distinct subclasses of myeloid neoplasia
T Kewan, A Durmaz, W Bahaj, C Gurnari, L Terkawi, H Awada, OD Ogbue, ...
Nature communications 14 (1), 3136, 2023
强制性开放获取政策： US National Institutes of Health
The evolution of paroxysmal nocturnal haemoglobinuria depends on intensity of immunosuppressive therapy
T Bat, ON Abdelhamid, SK Balasubramanian, A Mai, T Radivoyevitch, ...
British journal of haematology 182 (5), 730, 2017
强制性开放获取政策： US National Institutes of Health
Novel scheme for defining the clinical implications of TP53 mutations in myeloid neoplasia
W Bahaj, T Kewan, C Gurnari, A Durmaz, B Ponvilawan, I Pandit, ...
Journal of Hematology & Oncology 16 (1), 91, 2023
强制性开放获取政策： US National Institutes of Health
PAK4 and NAMPT as novel therapeutic targets in diffuse large B-cell lymphoma, follicular lymphoma, and mantle cell lymphoma
HY Khan, MH Uddin, SK Balasubramanian, N Sulaiman, M Iqbal, ...
Cancers 14 (1), 160, 2021
强制性开放获取政策： US National Institutes of Health
Multi-institutional study evaluating clinical outcome with allogeneic hematopoietic stem cell transplantation after blinatumomab in patients with B-cell acute lymphoblastic …
T Badar, A Szabo, M Litzow, M Burkart, I Yurkiewicz, S Dinner, M Hefazi, ...
Bone Marrow Transplantation 56 (8), 1998-2004, 2021
强制性开放获取政策： US National Institutes of Health
Therapeutic outcomes using subcutaneous low dose alemtuzumab for acquired bone marrow failure conditions
S Thota, BJ Patel, M Sadaps, S Balasubramanian, S Sanikommu, ...
British journal of haematology 183 (1), 133, 2017
强制性开放获取政策： US National Institutes of Health
Distinct clinical and biological implications of various DNMT3A mutations in myeloid neoplasms
SK Balasubramanian, M Aly, Y Nagata, T Bat, BP Przychodzen, ...
Leukemia 32 (2), 550-553, 2018
强制性开放获取政策： US National Institutes of Health
BMET-17. THE PROGNOSTIC ROLE OF TUMOR VOLUME IN THE OUTCOME OF PATIENTS WITH SINGLE BRAIN METASTASIS AFTER STEREOTACTIC RADIOSURGERY
E Bennett, M Vogelbaum, G Barnett, L Angelov, S Chao, E Murphy, J Yu, ...
Neuro-Oncology 18 (suppl_6), vi29-vi30, 2016
强制性开放获取政策： National Institute for Health Research, UK, Netherlands Organisation for …
出版信息和资助信息由计算机程序自动确定